ARGX argenx SE
$851.29
argenx SE (ARGX) is expected to report earnings on October 22, 2026, before the market open. The consensus earnings estimate is $7.50 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -2.3% since its last earnings release on July 23, 2026.
argenx SE Beat Expectations
Thursday, July 23, 2026 · 1:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Oct 22
Thursday · 1:00 AM ET
Earnings Whisper
-
vs $7.50
Rev est $1.57B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$874.98
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About argenx SE
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.
Sector
Healthcare
Industry
Biotechnology